Publikationen in Zusammenarbeit mit Forschern von GlaxoSmithKline (United Kingdom) (8)

2020

  1. Five insights from the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1135-1159

  2. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1160-1203

  3. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1204-1222

  4. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1223-1249

  5. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1250-1284

2019

  1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study

    JAMA Oncology, Vol. 5, Núm. 12, pp. 1749-1768

  2. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050

    The Lancet, Vol. 393, Núm. 10187, pp. 2233-2260

2018

  1. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

    The Lancet, Vol. 392, Núm. 10159, pp. 2091-2138